WebThis journal aims to review the most important, recently published treatment option advances in the field of oncology. By providing clear, insightful, balanced contributions by international experts, the journal intends to … WebAnnals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review …

Current Treatment Options in Psychiatry Home - Springer

WebApr 11, 2024 · IrEC is one of the most frequent irAEs associated with ICI use, affecting 5%-17% of patients treated with anti–PD-L1 therapy, 35%-40% of patients treated with anti–cytotoxic T-cell lymphocyte-4 (CTLA-4) therapy, and 32%-50% of patients receiving this combination. 6, 8, 9 IrEC is the irAE that most commonly leads to treatment interruption … WebOct 23, 2024 · Curr Treat Options Oncol. 2024 Oct 23;22(12):109. doi: ... Many possible drug-able targets have been identified. However, the impact of these strategies in improving SS outcome is still limited, thus making current and future research strongly needed to improve the survival of patients with SS. easy healthy shepherd\u0027s pie

The Biology of Synovial Sarcoma: State-of-the-Art and Future ...

WebLWW WebAug 3, 2024 · (1) Background. Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe mucocutaneous reactions, characterized by extensive necrosis and detachment of the epidermis. (2) Case presentation. We present a case of a 46-year-old patient with late-stage high-grade serous ovarian cancer who was primarily treated with … WebCurrent Treatment Options in Oncology Current Treatment Options in Oncology Submission guidelines Submission guidelines Contents Instructions for Authors Types of papers Manuscript Submission Title Page Text References Tables Artwork and Illustrations Guidelines Supplementary Information (SI) Ethical Responsibilities of Authors curious george wiki